Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,815 | 106,278 | 113,403 | 124,050 | 151,291 |
| Marketable Securities | 200,142 | 264,984 | 244,036 | 249,524 | 284,064 |
| Receivables | 668 | 986 | N/A | N/A | 9,610 |
| Other current assets | 190 | 0 | 0 | 0 | 0 |
| TOTAL | $314,389 | $384,621 | $369,497 | $392,325 | $464,307 |
| Non-Current Assets | |||||
| PPE Net | 9,109 | 53,780 | 53,485 | 51,029 | 51,471 |
| Other Non-Current Assets | 73,782 | 29,726 | 26,941 | 13,437 | 13,859 |
| TOTAL | $82,891 | $83,506 | $80,426 | $64,466 | $65,330 |
| Total Assets | $397,280 | $468,127 | $449,923 | $456,791 | $529,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,945 | 17,368 | 16,543 | 12,301 | 17,355 |
| Accrued Expenses | 16,381 | 25,150 | 19,140 | 15,323 | 12,786 |
| Other current liabilities | 8,303 | 9,057 | 9,267 | 7,367 | 7,901 |
| TOTAL | $101,562 | $105,786 | $86,150 | $88,830 | $84,194 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 50,943 | 40,760 | 31,226 | 40,968 | 35,497 |
| Other Non-Current Liabilities | 26,402 | 27,019 | 26,789 | 13,953 | 14,595 |
| TOTAL | $71,402 | $82,727 | $53,632 | $36,423 | $46,406 |
| Total Liabilities | $172,964 | $188,513 | $139,782 | $125,253 | $130,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,736 | 3,724 | 3,537 | 3,390 | 3,363 |
| Common Shares | 9 | 9 | 9 | 8 | 8 |
| Retained earnings | -1,552,827 | -1,464,722 | -1,371,373 | -1,286,709 | -1,202,916 |
| Other shareholders' equity | -1,892 | -368 | 24 | 62 | 161 |
| TOTAL | $224,316 | $279,614 | $310,141 | $331,538 | $399,037 |
| Total Liabilities And Equity | $397,280 | $468,127 | $449,923 | $456,791 | $529,637 |